科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/02/18 | 4,529 | 4,585 | 4,459 | 4,459 | +99 | +2.3% | 175,600 |
| 2025/02/17 | 4,360 | 4,423 | 4,360 | 4,360 | +13 | +0.3% | 96,100 |
| 2025/02/14 | 4,302 | 4,347 | 4,297 | 4,347 | +47 | +1.1% | 60,400 |
| 2025/02/13 | 4,269 | 4,322 | 4,269 | 4,300 | +35 | +0.8% | 81,600 |
| 2025/02/12 | 4,279 | 4,297 | 4,234 | 4,265 | +15 | +0.4% | 111,300 |
| 2025/02/10 | 4,239 | 4,275 | 4,198 | 4,250 | -1 | ±0% | 115,200 |
| 2025/02/07 | 4,203 | 4,388 | 4,195 | 4,251 | -92 | -2.1% | 205,000 |
| 2025/02/06 | 4,330 | 4,355 | 4,294 | 4,343 | +65 | +1.5% | 205,400 |
| 2025/02/05 | 4,200 | 4,278 | 4,195 | 4,278 | +73 | +1.7% | 118,200 |
| 2025/02/04 | 4,210 | 4,238 | 4,192 | 4,205 | -5 | -0.1% | 88,400 |
| 2025/02/03 | 4,219 | 4,240 | 4,195 | 4,210 | -10 | -0.2% | 139,900 |
| 2025/01/31 | 4,265 | 4,268 | 4,215 | 4,220 | -61 | -1.4% | 108,600 |
| 2025/01/30 | 4,268 | 4,285 | 4,249 | 4,281 | +17 | +0.4% | 111,400 |
| 2025/01/29 | 4,309 | 4,311 | 4,251 | 4,264 | -55 | -1.3% | 99,500 |
| 2025/01/28 | 4,336 | 4,336 | 4,287 | 4,319 | +6 | +0.1% | 82,400 |
| 2025/01/27 | 4,337 | 4,338 | 4,289 | 4,313 | +21 | +0.5% | 64,500 |
| 2025/01/24 | 4,235 | 4,368 | 4,233 | 4,292 | +57 | +1.3% | 131,700 |
| 2025/01/23 | 4,231 | 4,254 | 4,194 | 4,235 | -3 | -0.1% | 142,600 |
| 2025/01/22 | 4,276 | 4,276 | 4,226 | 4,238 | +11 | +0.3% | 103,000 |
| 2025/01/21 | 4,226 | 4,243 | 4,212 | 4,227 | -6 | -0.1% | 81,600 |
| 2025/01/20 | 4,259 | 4,282 | 4,226 | 4,233 | -29 | -0.7% | 119,800 |
| 2025/01/17 | 4,252 | 4,280 | 4,236 | 4,262 | +10 | +0.2% | 90,900 |
| 2025/01/16 | 4,281 | 4,297 | 4,246 | 4,252 | -29 | -0.7% | 113,000 |
| 2025/01/15 | 4,269 | 4,297 | 4,244 | 4,281 | +24 | +0.6% | 115,000 |
| 2025/01/14 | 4,282 | 4,310 | 4,253 | 4,257 | -17 | -0.4% | 146,300 |
| 2025/01/10 | 4,312 | 4,338 | 4,256 | 4,274 | -44 | -1% | 102,100 |
| 2025/01/09 | 4,438 | 4,440 | 4,290 | 4,318 | -121 | -2.7% | 111,100 |
| 2025/01/08 | 4,515 | 4,515 | 4,439 | 4,439 | -98 | -2.2% | 130,700 |
| 2025/01/07 | 4,579 | 4,599 | 4,525 | 4,537 | -40 | -0.9% | 176,900 |
| 2025/01/06 | 4,515 | 4,603 | 4,483 | 4,577 | +64 | +1.4% | 294,000 |
| 2024/12/30 | 4,500 | 4,530 | 4,464 | 4,513 | +13 | +0.3% | 202,700 |
| 2024/12/27 | 4,563 | 4,591 | 4,434 | 4,500 | +326 | +7.8% | 528,800 |
| 2024/12/26 | 4,163 | 4,174 | 4,143 | 4,174 | +2 | ±0% | 78,900 |
| 2024/12/25 | 4,221 | 4,224 | 4,141 | 4,172 | -50 | -1.2% | 63,600 |
| 2024/12/24 | 4,258 | 4,258 | 4,213 | 4,222 | -35 | -0.8% | 90,800 |
| 2024/12/23 | 4,237 | 4,271 | 4,221 | 4,257 | +20 | +0.5% | 99,600 |
| 2024/12/20 | 4,216 | 4,251 | 4,203 | 4,237 | +31 | +0.7% | 192,200 |
| 2024/12/19 | 4,251 | 4,280 | 4,182 | 4,206 | -97 | -2.3% | 132,900 |
| 2024/12/18 | 4,310 | 4,326 | 4,282 | 4,303 | +3 | +0.1% | 106,800 |
| 2024/12/17 | 4,305 | 4,385 | 4,293 | 4,300 | +9 | +0.2% | 188,900 |
| 2024/12/16 | 4,300 | 4,311 | 4,249 | 4,291 | -21 | -0.5% | 103,700 |
| 2024/12/13 | 4,319 | 4,347 | 4,293 | 4,312 | -34 | -0.8% | 162,900 |
| 2024/12/12 | 4,315 | 4,381 | 4,315 | 4,346 | +37 | +0.9% | 207,900 |
| 2024/12/11 | 4,336 | 4,360 | 4,302 | 4,309 | -27 | -0.6% | 113,700 |
| 2024/12/10 | 4,390 | 4,403 | 4,266 | 4,336 | -46 | -1% | 190,800 |
| 2024/12/09 | 4,357 | 4,405 | 4,336 | 4,382 | +33 | +0.8% | 228,700 |
| 2024/12/06 | 4,339 | 4,369 | 4,321 | 4,349 | +28 | +0.6% | 203,500 |
| 2024/12/05 | 4,265 | 4,321 | 4,256 | 4,321 | +66 | +1.6% | 223,700 |
| 2024/12/04 | 4,312 | 4,312 | 4,248 | 4,255 | -57 | -1.3% | 141,100 |
| 2024/12/03 | 4,325 | 4,345 | 4,298 | 4,312 | -5 | -0.1% | 218,700 |
51～
100
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 407,200円 | +30.5% | +111.0% | 4.67% | 11.48倍 | 1.00倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 日本新薬 | 373,500円 | +7.9% | +8.9% | 3.32% | 7.99倍 | 1.07倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| サワイＧＨＤ | 203,300円 | +4.0% | +25.4% | 2.61% | 8.89倍 | 1.17倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| キッセイ薬 | 379,500円 | +14.5% | -2.3% | 2.37% | 13.88倍 | 0.74倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| サンバイオ | 229,900円 | - | - | 0.00% | - | 106.48倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
